Serum microRNA-1 and microRNA-133a levels reflect myocardial steatosis in uncomplicated type 2 diabetes | Scientific Reports
Circulating MicroRNAs: Potential and Emerging Biomarkers for Diagnosis of Cardiovascular and Cerebrovascular Diseases
Identification of cardiac-related circulating microRNA profile in human chronic heart failure | Oncotarget
MicroRNA plasma expression over time. A miR-1, B miR-133a, C miR-30a, D... | Download Scientific Diagram
microRNA‐based diagnostic and therapeutic applications in cancer medicine - Sempere - 2021 - WIREs RNA - Wiley Online Library
Up-regulated miR-133a orchestrates epithelial-mesenchymal transition of airway epithelial cells | Scientific Reports
ORIGINAL ARTICLE Plasma MicroRNA-133a as a Potential Predictor for Coronary Artery Stenosis Severity
Plasma microRNA-133a is a new marker for both acute myocardial infarction and underlying coronary artery stenosis | Journal of Translational Medicine | Full Text
PDF) Plasma microRNA-133a is a new marker for both acute myocardial infarction and underlying coronary artery stenosis
MicroRNAs and Myocardial Infarct: Investigating the Controversial Role of Second Generation Biomarkers. | Semantic Scholar
Cardiac-specific miRNA in cardiogenesis, heart function, and cardiac pathology (with focus on myocardial infarction) - Journal of Molecular and Cellular Cardiology
ORIGINAL ARTICLE Plasma MicroRNA-133a as a Potential Predictor for Coronary Artery Stenosis Severity
miR-223-3p and miR-24-3p as novel serum-based biomarkers for myotonic dystrophy type 1: Molecular Therapy - Methods & Clinical Development
MicroRNAs in cardiovascular disease - ScienceDirect
Plasma microRNA-133a is a new marker for both acute myocardial infarction and underlying coronary artery stenosis | Journal of Translational Medicine | Full Text
Diagnostics | Free Full-Text | MicroRNAs as Biomarkers of Systemic Changes in Response to Endurance Exercise—A Comprehensive Review
Plasma microRNA-133a is a new marker for both acute myocardial infarction and underlying coronary artery stenosis | Journal of Translational Medicine | Full Text
Plasma microRNA-133a is a new marker for both acute myocardial infarction and underlying coronary artery stenosis | Journal of Translational Medicine | Full Text
MicroRNAs as Potential Predictors of Postoperative AF | ECR Journal
ORIGINAL ARTICLE Plasma MicroRNA-133a as a Potential Predictor for Coronary Artery Stenosis Severity
IJMS | Free Full-Text | Challenges in Using Circulating Micro-RNAs as Biomarkers for Cardiovascular Diseases
Diagnostics | Free Full-Text | MicroRNAs as Biomarkers in Cancer
Disparate miRNA expression in serum and plasma of patients with acute myocardial infarction: a systematic and paired comparative analysis | Scientific Reports
Non-canonical features of microRNAs: paradigms emerging from cardiovascular disease | Nature Reviews Cardiology
Plasma Circulating Extracellular RNAs in Left Ventricular Remodeling Post-Myocardial Infarction - eBioMedicine
Plasma MicroRNA-133a as a Potential Biomarker for Acute Coronary Syndrome
The plasma miR-125a, miR-361 and miR-133a are promising novel biomarkers for Late-Onset Hypogonadism | Scientific Reports
Frontiers | Circulating MicroRNAs: Biogenesis and Clinical Significance in Acute Myocardial Infarction
Plasma microRNA-133a is a new marker for both acute myocardial infarction and underlying coronary artery stenosis | Journal of Translational Medicine | Full Text
